Quality Systems

Sep 07, 2016
By BioPharm International Editors
FDA issued a warning letter to Lima & Pergher Industria e Comercio S/A for CGMP violations.
Sep 07, 2016
By BioPharm International Editors
The Indian facility was cited for a range of quality and data integrity violations.
Sep 01, 2016
By BioPharm International Editors
FDA cites two Xinxiang Tuoxin Biochemical facilities with CGMP deviations.
Sep 01, 2016
BioPharm International
Innovations in electrophoresis and chromatography upstream of protein characterization can accelerate research.
Sep 01, 2016
BioPharm International
Airlines, airports, freight forwarders, and other cold-chain partners are taking a crash course in pharma cGMPs.
Aug 29, 2016
By BioPharm International Editors
The agency sent a warning letter to Cape Apothecary for adulterated drugs.
Aug 19, 2016
By BioPharm International Editors
The company is voluntarily recalling one lot of Oxacillin for Injection, USP, 10 g.
Aug 17, 2016
By BioPharm International Editors
The Chinese facility was cited for data integrity violations.
Aug 15, 2016
By BioPharm International Editors
The agency has adopted guidelines on the pharmacovigilance of biological drugs.
Aug 09, 2016
By BioPharm International Editors
The company is voluntarily recalling liquid products due to possible Burkholderia cepacia contamination.
native1_300x100
lorem ipsum